X hits on this document

Word document

Adverse Outcomes in Blood and Blood Component Therapy - page 19 / 19

86 views

0 shares

0 downloads

0 comments

19 / 19

46.

Brown P,  Cervenáková L, McShane LM, Barber P, Rubenstein R, Drohan WN. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans Transfusion 1999; 39: 1169-1178

47.

Lowenthal RM, Challis DR, Griffiths AE, Chappell RA, Goulder PJ. Transfusion-associated graft-versus-host disease: report of an occurrence following the administration of irradiated blood Transfusion 1993; 33:524-529

48.

Anolik JH, Blumberg N, Snider J, Francis CW. Posttransfusion purpura secondary to an alloantibodyreactive with HPA-5a (Brb) Transfusion 2001 41: 633-636

49.

Post Transfusion Purpura. Available at URL: http://www.psbc.org/medical/transfusion/bcrm/section_c/_frm/frm_p3_post_purpura.htm accessed September 23, 2001

50.

Kaplan C. Platelet immunology and post-transfusion alloimmunisation Hématologie. 1997;3(1): 45-51

51.

Evenson DA, Stroncek DF, Pulkrabek S, Perry EH, Radford J, Miller JS, Verfaillie C. Posttransfusion purpura following bone marrow transplantation Transfusion 1995;35: 688-693

52.

Vichinsky EP, Luban NLC, Wright E, Olivieri N, Driscoll C, Pegelow CH, Adams RJ Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial Transfusion 2001 41: 1086-1092

53.

Schonewille H, Haak HL, van Zijl AM Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases Transfusion 1999;39:763-771

54.

Cazzola M, Borgna-Pignatti C, Locatelli F, Ponchio L, Beguin Y, De Stefano P.A moderate transfusion regimen may reduce iron loading in beta- thalassemia major without producing excessive expansion of erythropoiesis Transfusion 1997 37: 135-140.

55.

Barton JC, Preston BL, McDonnell SM, Rothenberg BE. Severity of iron overload in hemochromatosis: effect of volunteer blood donation before diagnosis Transfusion 2001 41: 123-129.

56.

Leukocyte Associated Risks of Transfusion. Available at URL: http://www.bloodtransfusion.com/complications.asp Accessed September 31, 2001

57.

Ghio M, Contini P, Mazzei C, Merlo A, Filaci G, Setti M, Indiveri F, Puppo F. In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules:do they play a role in autologous blood transfusion? Transfusion 2001 41: 988-996

58.

Perrotta PL, Snyder EL. Non-infectious complications of transfusion therapy. Blood Rev 2001;15(2):69-83

Document info
Document views86
Page views102
Page last viewedSun Dec 04 06:07:00 UTC 2016
Pages19
Paragraphs174
Words12213

Comments